Timothy G. Murray
About
In The Last Decade
Timothy G. Murray
266 papers receiving 6.2k citations
Hit Papers
Peers
Comparison fields: 5 of 146
- Ophthalmology 5.3k
- Radiology, Nuclear Medicine and Imaging 2.4k
- Molecular Biology 1.0k
- Oncology 664
- Pulmonary and Respiratory Medicine 479
Countries citing papers authored by Timothy G. Murray
This map shows the geographic impact of Timothy G. Murray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timothy G. Murray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timothy G. Murray more than expected).
Fields of papers citing papers by Timothy G. Murray
This network shows the impact of papers produced by Timothy G. Murray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timothy G. Murray. The network helps show where Timothy G. Murray may publish in the future.
Co-authorship network of co-authors of Timothy G. Murray
This figure shows the co-authorship network connecting the top 25 collaborators of Timothy G. Murray. A scholar is included among the top collaborators of Timothy G. Murray based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Timothy G. Murray. Timothy G. Murray is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 2 | |
| 3 | 1 | |
| 4 | 1 | |
| 5 | 25 | |
| 6 | Intravitreal Bevacizumab for the Treatment of Pediatric Retinal and Choroidal Diseases: Extended Follow Up | 1 |
| 7 | 2 | |
| 8 | 29 | |
| 9 | 9 | |
| 10 | 10 | |
| 11 | Concomitant bilateral intravitreal anti-VEGF injections for the treatment of exudative age-related macular degeneration | 5 |
| 12 | Intravitreal injection analysis at the Bascom Palmer Eye Institute: evaluation of clinical indications for the treatment and incidence rates of endophthalmitis | 3 |
| 13 | Intraoperative Spectral Domain Optical Coherence Tomography (SD-OCT) Imaging of Complex Pediatric Retinal Disease | 1 |
| 14 | 94 | |
| 15 | Targeting the Tumor Microenvironment as a Therapeutic Strategy for Retinoblastoma | 1 |
| 16 | Delayed–onset Bleb–Associated Endophthalmitis: Clinical Features and Visual Acuity Outcomes | 17 |
| 17 | 7 | |
| 18 | Endophthalmitis: Are Subconjunctival Antibiotics Necessary? | 0 |
| 19 | Subconjunctival Anecortave Acetate, an Angiostatic Steroid, in the Treatment of a Murine Model of Retinoblastoma | 1 |
| 20 | Résurgences baroques : Les trajectoires d'un processus transculturel | 0 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.